(PharmaNewsWire.Com, June 19, 2018 ) Woodridge, USA Jun 2018(News) - Safety Lancets is also known as Prosthodontics. Safety Lancets are mostly in use for the improvement of damaged or deficient teeth. It improves functions as well as appearance of teeth. The global Safety Lancets market is expected to reach USD 5659.4 million by 2023 at a CAGR of 5.5% during the forecasted period. The global Safety Lancets Market has been segmented on the basis of type which comprises denture, crown, bridges, veneer, abutment, inlays. Of which bridges segment holds 27.6% market share in global dental prosthetic market by type and expected to reach USD 1601.9 million by 2023 from USD 1071.8 million in 2016. Crown is expected to grow at a fastest CAGR of 6.4% from 2017 to 2023. On the basis of type of material it is segmented into porcelain-fused-to-metal (pfm), metal, all ceramic, and others. Of which porcelain-fused-to-metal (PFM) segment holds 39.5% market share of Safety Lancets by type of material and expected to reach US$ 2132.8 million by 2023.
• The leading market players in the global Safety Lancets market include : Henry Schein • Inc. (US) • DENTSPLY Sirona (US) • 3M (US) • Institut Straumann AG (Switzerland) • Zimmer Biomet (US) • Nobel Biocare (Part of Danaher corporation) (US) • Ivoclar Vivadent AG (Liechtenstein) • Osstem Prosthetics (South Korea) • Planmeca OY (Finland) • CAMLOG Biotechnologies AG (Switzerland)
Study objectives: • To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Safety Lancets market • To provide insights about factors influencing and affecting the market growth • To provide historical and forecast revenue of the market segments and sub-segments with respect to countries • To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global Safety Lancets market. • To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
Target Audience: • Safety Lancets suppliers • Safety Lancets manufacturers • Dental research laboratories • Potential Investors • Medical Research Institutes • Key Executive (CEO and COO) and Strategy Growth Manager • Research Companies
Key Findings: • North America accounted for the largest market share in the global Safety Lancets market, USD 1490.8 million in 2016 and expected to reach by USD 2031.7 million by 2023 at a fastest CAGR of 6.3% • Crown market segment is the fastest growing segment with a CAGR of and 5.3% in the global Safety Lancets market, by types • Hospitals and clinics is contributing remarkable share in the market registering 80.7% in the global Safety Lancets market, by end users in 2016
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
